HCA Healthcare, Inc. HCA

FY2025 · ended Dec 31, 2025 · Revenue $75.60B, +7.1% YoY · Filed Feb 10, 2026

HCA Healthcare, Inc. (HCA) files with the SEC under industry code 8062, Services-General Medical & Surgical Hospitals, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $75.6 billion and net income of $6.8 billion. Free cash flow was $7.7 billion. As of Sep 30, 2026 it held $1.4 billion in cash and investments and $52.4 billion in total debt.

Revenue (TTM)
$78.70B
+5.8% vs year-ago TTM
Net income (TTM)
$6.78B
+6.8% vs year-ago TTM
Operating cash flow (TTM)
$11.17B
-13.0% vs year-ago TTM
Free cash flow (TTM)
$5.97B
-26.2% vs year-ago TTM
EPS (TTM)
$30.20
+17.0% vs year-ago TTM
Dividend per share
$2.88
+9.1% vs prior year
Shares outstanding
223.62M
-10.0% vs prior year
Net cash
$-51.05B
as of Sep 30, 2026
Operating margin
—

Company profile

Industry
Services-General Medical & Surgical Hospitals, NEC (SIC 8062)
Listed as
HCA (NYSE)
Fiscal year ends
December 31
Headquarters
Nashville, TN
SEC filer status
Large accelerated filer
SEC CIK
860730
Former names
HCA Holdings, Inc. (until May 5, 2017); HCA INC/TN (until Nov 24, 2010); HCA THE HEALTHCARE CO (until May 21, 2001); HCA-THE HEALTHCARE CO (until Feb 14, 2001); COLUMBIA HCA HEALTHCARE CORP (until May 19, 2000)

Other Services-General Medical & Surgical Hospitals, NEC companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$75.6B
$70.6B
$65.0B
$60.2B
$58.8B
Net income
$6.8B
$5.8B
$5.2B
$5.6B
$7.0B
Diluted EPS
$28.33
$22.00
$18.97
$19.15
$21.16
Operating cash flow
$12.6B
$10.5B
$9.4B
$8.5B
$9.0B
Free cash flow
$7.7B
$5.6B
$4.7B
$4.1B
$5.4B
Total assets
$60.7B
$59.5B
$56.2B
$52.4B
$50.7B
Stockholders' equity
-$6.0B
-$2.5B
-$1.8B
-$2.8B
-$933.0M
Cash and investments
$1.5B
$2.5B
$1.4B
$1.3B
$2.0B
Total debt
$49.5B
$46.0B
$42.6B
$40.9B
$37.4B

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Other events
Nov 2, 2026 Nov 2, 2026
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Oct 27, 2026 Oct 27, 2026
8-K Current report
New debt, Other events
Jul 29, 2026 Jul 29, 2026
10-Q Quarterly report Jul 28, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jul 24, 2026 Jul 24, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.